^SURECardio Prospective

^SURECardio Prospective is a unique application that dramatically lowers patient dose during coronary CTA exams.

• Proprietary scan technique resulting in a fast, ultra-high resolution exam
• Unique adaptive arrhythmia rejection enables reliable diagnostic accuracy
• Ultra-low patient dose with a reduction of up to 80%
• ^SURECardio is a clinically proven application utilized in the CorE64 worldwide multicenter clinical trial

Variable Helical Pitch™ (vHP)

Automated workflow for consistent results and improved productivity. vHP is an advanced scanning mode that enables two different scan protocols with two different scan parameters to be combined into a single helical examination.

• vHP can be used to acquire a gated and a non-gated scan in a single examination using a single contrast bolus
  • Coronary artery CTA (ECG gated using Cardiac Pitch)
  • CTA of the aorta (non-gated using a standard CTA pitch)
• Combine trauma applications such as a brain scan (detailed pitch) and body scan (standard pitch) in one continuous scan
• Dose reduction of up to 55% improves patient care
• Reproducible results every time, day or night

phaseXact

This software automatically locates the optimal phase of the heartbeat and assures the best image quality, while decreasing image reconstruction time by at least 50 percent and reducing storage requirements. Learn more about phaseXact »

^SURESubtraction

Taking CT-DSA to a higher level of performance by automating digital subtraction of the intra- and extra-cranial vessels from bone. Learn more about ^SURESubtraction »

^SUREPlaque

This advanced visualization tool enables clinicians to make better decisions and improve workflow:

• Visualize coronary vessel anatomy and disease with ease using color defined HU ranges
• Quantify plaque burden and coronary remodeling
• Characterize lesions as either calcified or non-calcified in the lumen and vessel wall